ATF5 anticorps (Middle Region)
Aperçu rapide pour ATF5 anticorps (Middle Region) (ABIN929026)
Antigène
Voir toutes ATF5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée
- Souris, Rat (Rattus), Boeuf (Vache), Grenouille, Poisson zebré (Brachydanio rerio)
-
Purification
- Purified
-
Immunogène
- ATF5 antibody was raised in rabbit using the middle region of ATF5 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ATF5 Blocking Peptide, (ABIN5612197), is also available for use as a blocking control in assays to test for specificity of this ATF5 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ATF5 (Activating Transcription Factor 5 (ATF5))
-
Autre désignation
- ATF5
-
Sujet
- ATF5 belongs to the bZIP family. It is transcriptional activator which binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters and blocks the differentiation of neuroprogenitor cells into neurons. Its transcriptional activity is enhanced by CCND3 and slightly inhibited by CDK4. Loss of ATF5 is associated with hepatocellular carcinoma. Synonyms: Polyclonal ATF5 antibody, Anti-ATF5 antibody, activating transcription factor 5 antibody, ATFX antibody, FLJ34666 antibody, HMFN0395 antibody.
-
Pathways
- Myometrial Relaxation and Contraction
Antigène
-